Precigen’s Annual Meeting Decisions and Director Departure
Company Announcements

Precigen’s Annual Meeting Decisions and Director Departure

Precigen (PGEN) just unveiled an announcement.

At Precigen, Inc.’s 2024 Annual Meeting, stockholders voted to expand the 2023 Omnibus Incentive Plan by an additional 2 million shares, following prior Board approval contingent on shareholder consent. Furthermore, the election of directors, ratification of the company’s public accounting firm Deloitte & Touche LLP for the year, and approval of executive compensation were confirmed. Dean Mitchell concluded his Board service, opting not to seek re-election without any disputes related to the company’s operations or policies.

Learn more about PGEN stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPrecigen Regains Full Control of Technology Post Agreement Termination
TipRanks Auto-Generated NewsdeskPrecigen Aligns Executive Incentives with FDA Approval Goals
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App